Ophthalmic composition for the treatment of ocular infection
An ophthalmic composition for administration to an eye of a patient for the treatment of an ocular infection. The ophthalmic composition contains an ε-polylysine (εPL) in an amount effective to treat or control or prevent the ocular infection.
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
12.01.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | An ophthalmic composition for administration to an eye of a patient for the treatment of an ocular infection. The ophthalmic composition contains an ε-polylysine (εPL) in an amount effective to treat or control or prevent the ocular infection. |
---|---|
Bibliography: | Application Number: AU20150275896 |